How I treat hematologic emergencies in adults with acute leukemia
- PMID: 22700723
- DOI: 10.1182/blood-2012-04-424440
How I treat hematologic emergencies in adults with acute leukemia
Abstract
Acute myeloid leukemia and acute lymphoblastic leukemia remain devastating diseases. Only approximately 40% of younger and 10% of older adults are long-term survivors. Although curing the leukemia is always the most formidable challenge, complications from the disease itself and its treatment are associated with significant morbidity and mortality. Such complications, discussed herein, include tumor lysis, hyperleukocytosis, cytarabine-induced cellebellar toxicity, acute promyelocytic leukemia differentiation syndrome, thrombohemorrhagic syndrome in acute promyelocytic leukemia, L-asparaginase-associated thrombosis, leukemic meningitis, neutropenic fever, neutropenic enterocolitis, and transfussion-associated GVHD. Whereas clinical trials form the backbone for the management of acute leukemia, emergent clinical situations, predictable or not, are common and do not readily lend themselves to clinical trial evaluation. Furthermore, practice guidelines are often lacking. Not only are prospective trials impractical because of the emergent nature of the issue at hand, but clinicians are often reluctant to randomize such patients. Extensive practical experience is crucial and, even if there is no consensus, management of such emergencies should be guided by an understanding of the underlying pathophysiologic mechanisms.
Similar articles
-
Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.Klin Padiatr. 2009 Nov-Dec;221(6):374-8. doi: 10.1055/s-0029-1239533. Epub 2009 Nov 4. Klin Padiatr. 2009. PMID: 19890790
-
Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?Pharmacotherapy. 2017 Sep;37(9):1052-1072. doi: 10.1002/phar.1977. Epub 2017 Jul 31. Pharmacotherapy. 2017. PMID: 28654205 Review.
-
[Acute leukemia in adults].Pathologe. 2015 Sep;36(5):503-17; quiz 518-9. doi: 10.1007/s00292-015-0087-y. Pathologe. 2015. PMID: 26314268 Review. German.
-
Coexistence of T-cell lymphoblastic lymphoma and acute myeloid leukemia mimicking acute lymphocytic leukemia.Indian J Pathol Microbiol. 2018 Jul-Sep;61(3):464-467. doi: 10.4103/IJPM.IJPM_6_18. Indian J Pathol Microbiol. 2018. PMID: 30004087 No abstract available.
-
Leukemias.Clin Obstet Gynecol. 2002 Sep;45(3):866-78. doi: 10.1097/00003081-200209000-00033. Clin Obstet Gynecol. 2002. PMID: 12370628 Review. No abstract available.
Cited by
-
Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis.Transfusion. 2020 Oct;60(10):2360-2369. doi: 10.1111/trf.15994. Epub 2020 Aug 10. Transfusion. 2020. PMID: 32776542 Free PMC article.
-
Complications and management of coagulation disorders in leukemia patients.Blood Lymphat Cancer. 2017 Sep 18;7:61-72. doi: 10.2147/BLCTT.S125121. eCollection 2017. Blood Lymphat Cancer. 2017. PMID: 31360085 Free PMC article. Review.
-
Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation.Cancers (Basel). 2024 May 15;16(10):1887. doi: 10.3390/cancers16101887. Cancers (Basel). 2024. PMID: 38791965 Free PMC article.
-
Kidney diseases associated with haematological cancers.Nat Rev Nephrol. 2015 Aug;11(8):478-90. doi: 10.1038/nrneph.2015.81. Epub 2015 Jun 2. Nat Rev Nephrol. 2015. PMID: 26035773 Review.
-
[Leukostasis and tumor lysis: important complications of hyperleukocytosis].Internist (Berl). 2013 Sep;54(9):1051-60. doi: 10.1007/s00108-013-3260-5. Internist (Berl). 2013. PMID: 23943008 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical